The state of uric acid in Iraqi patients with Parkinson disease
Keywords:
central nervous system, Parkinson's disease, uric acid, neurodegenerative disorderAbstract
Uric acid has recently been proposed as a possible cause of Parkinson's disease (PD). The researchers wanted to see how uric acid levels were in persons with Parkinson's disease compared to an age-matched healthy control group. Researchers employed a case control study and a random comparison of plasma uric acid concentrations of collected samples in a clinical neurology department ward at Baghdad education hospital/Medical City and a Parkinson's disease movement disorder clinic. Participants were enrolled in the study from October 2015 to October 2016. We looked examined blood Uric acid levels in 40 Parkinson's disease patients and 40 age-matched healthy controls after controlling for age, sex, race, and geographic location. The Most Important Outcome Measures: Suboptimal Uric acid concentrations have been seen in Parkinson's patients. The results indicated that patients with PD (65%) had lower uric acid levels than controls (22.5%), and that the mean uric acid concentration in PD was (3.24) considerably (P.05) lower than in controls (4.08). The study's findings show that PD patients had much lower uric acid levels than healthy controls. These findings suggest that uric acid may have a role in Parkinson's disease.
Downloads
References
De Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006;5(6):525-535.
Sveinbjornsdottir S. The clinical symptoms of Parkinson's disease. Journal of Neurochemistry. 2016 Oct 1;139(S1):318-324.
Kalia LV, Kalia SK, Lang AE. Disease‐modifying strategies for Parkinson's disease. Movement Disorders. 2015 Sep 15;30(11):1442-1450.
C. Warren Olanow , Anthony H.V. Schapira: Harrison's Neurology in Clinical Medicine, 3th edition, Elsevier Inc, 2013.CH.30: P 334.
Campdelacreu J. Parkinson's disease and Alzheimer disease: environmental risk factors. Neurología. 2014 Dec 31;29(9):541-549
McCrudden, Francis H. (2008). Uric Acid. BiblioBazaar.[ISBN missing]
https://en.wikipedia.org/wiki/Uric_acid - cite_ref-2 European Powder Diffraction Conference, EPDIC-9[fu
"Harmonisation of Reference Intervals" (PDF). Pathology Harmony (UK). Retrieved 13 August 2013.
Schlesinger, Ilana, and Naomi Schlesinger. "Uric acid in Parkinson's disease." Movement Disorders 23.12 (2008): 1653-1657.
Daniel SE, Lees AJ. Parkinson's Disease Society Brain Bank, London: overview and research. Journal of neural transmission. Supplementum. 1992 Dec;39:165-172.
Goetz CG, Poewe W, Rascol O, et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations the Movement Disorder Society Task Force on rating scales for Parkinson's disease. Movement disorders. 2004 Sep 1;19(9):1020-1028.
Alonso A, Sovell KA. Gout, Hyperuricemia, and Parkinson’s Disease: A Protective Effect?. Current rheumatology reports. 2010 Apr 1;12(2):149-155.
Alonso A, Rodríguez LA, Logroscino G, et al. Gout and risk of Parkinson disease A prospective study. Neurology. 2007 Oct 23;69(17):1696-700.
de Vera M, Rahman MM, Rankin J, et al. Gout and the Risk of Parkinson's Disease: A Cohort Study. Arthritis Rheum 2008;59:1549-1554.
Schwarzschild MA, Schwid SR, Marek K, et al. Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Archives of neurology. 2008 Jun 9;65(6):716-23.Evatt ML, DeLong MR, Khazai N, et al. Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease. Archives of neurology. 2008 Oct 13;65(10):1348-1352.
Andreadou E, Nikolaou C, Gournaras F, et al. Serum uric acid levels in patients with Parkinson's disease: their relationship to treatment and disease duration. Clinical neurology and neurosurgery. 2009 Nov 30;111(9):724-8.
Winquist A, Steenland K, Shankar A. Higher serum uric acid associated with decreased Parkinson's disease prevalence in a large community‐based survey. Movement disorders. 2010 May 15;25(7):932-936.
Jesús S, Pérez I, Cáceres‐Redondo MT, et al. Low serum uric acid concentration in Parkinson's disease in southern Spain. European journal of neurology. 2013 Jan 1;20(1):208-210.
Annanmaki T, Muuronen A, Murros K. Low plasma uric acid level in Parkinson's disease. Movement disorders. 2007 Jun 15;22(8):1133-1137.
Constantinescu R, Andreasson U, Holmberg B, et al. Serum and cerebrospinal fluid urate levels in synucleinopathies versus tauopathies. Acta Neurologica Scandinavica. 2013 Feb 1;127(2):e8-12.
Jenner P, Olanow CW. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology. 1996 Dec 1;47(6 Suppl 3):161S-70S.
Dexter DT, Wells FR, Lee AJ, et al. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. Journal of neurochemistry. 1989 Jun 1;52(6):1830-1836.
Mollenhauer B, Zhang J. Biochemical premotor biomarkers for Parkinson's disease. Movement Disorders. 2012 Apr 15;27(5):644-650.
Sakuta H, Suzuki K, Miyamoto T, et al. Serum uric acid levels in Parkinson's disease and related disorders. Brain and Behavior. 2016 Oct 1.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
